Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Genome-wide gene expression changes in the normal-appearing airway during the evolution of smoking-associated lung adenocarcinoma.

Kantrowitz J, Sinjab A, Xu L, McDowell TL, Sivakumar S, Lang W, Nunomura-Nakamura S, Fukuoka J, Nemer G, Darwiche N, Chami H, Tfayli A, Wistuba II, Scheet P, Fujimoto J, Spira AE, Kadara H.

Cancer Prev Res (Phila). 2018 Jan 30. pii: canprevres.0295.2017. doi: 10.1158/1940-6207.CAPR-17-0295. [Epub ahead of print]

PMID:
29382653
2.

A Volumetric Computed Tomography Analysis of the Normal Lung in Idiopathic Pulmonary Fibrosis: The Relationship with the Survival.

Ohkubo H, Taniguchi H, Kondoh Y, Yagi M, Furukawa T, Johkoh T, Arakawa H, Fukuoka J, Niimi A.

Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9508-17. [Epub ahead of print]

3.

Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non-Small Cell Lung Cancer.

Fujimoto D, Sato Y, Uehara K, Ishida K, Fukuoka J, Morimoto T, Kawachi H, Mori R, Ito M, Teraoka S, Nagata K, Nakagawa A, Otsuka K, Imai Y, Tomii K.

J Thorac Oncol. 2017 Dec 9. pii: S1556-0864(17)33072-1. doi: 10.1016/j.jtho.2017.11.123. [Epub ahead of print]

PMID:
29233789
4.

A Neonatal Case of Glial Choristoma of the Tongue Causing Airway Obstruction.

Machi H, Karata H, Yamane Y, Fukuoka J, Funakoshi Y, Moriuchi H.

Case Rep Otolaryngol. 2017;2017:2413035. doi: 10.1155/2017/2413035. Epub 2017 Sep 20.

5.

Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.

Nakamura S, Hayashi K, Imaoka Y, Kitamura Y, Akazawa Y, Tabata K, Groen R, Tsuchiya T, Yamasaki N, Nagayasu T, Fukuoka J.

PLoS One. 2017 Oct 19;12(10):e0186192. doi: 10.1371/journal.pone.0186192. eCollection 2017.

6.

Whole-slide imaging at primary pathological diagnosis: Validation of whole-slide imaging-based primary pathological diagnosis at twelve Japanese academic institutes.

Tabata K, Mori I, Sasaki T, Itoh T, Shiraishi T, Yoshimi N, Maeda I, Harada O, Taniyama K, Taniyama D, Watanabe M, Mikami Y, Sato S, Kashima Y, Fujimura S, Fukuoka J.

Pathol Int. 2017 Nov;67(11):547-554. doi: 10.1111/pin.12590. Epub 2017 Oct 5.

PMID:
28980740
7.

Application of microscope-based scanning software (Panoptiq) for the interpretation of cervicovaginal cytology specimens.

Groen R, Abe K, Yoon HS, Li Z, Shen R, Yoshikawa A, Nitanda T, Shimizu Y, Otsuka I, Fukuoka J.

Cancer Cytopathol. 2017 Dec;125(12):918-925. doi: 10.1002/cncy.21921. Epub 2017 Sep 28.

PMID:
28960858
8.

Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

Sivakumar S, Lucas FAS, McDowell TL, Lang W, Xu L, Fujimoto J, Zhang J, Futreal PA, Fukuoka J, Yatabe Y, Dubinett SM, Spira AE, Fowler J, Hawk ET, Wistuba II, Scheet P, Kadara H.

Cancer Res. 2017 Nov 15;77(22):6119-6130. doi: 10.1158/0008-5472.CAN-17-1605. Epub 2017 Sep 26.

PMID:
28951454
9.

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study.

Teraoka S, Fujimoto D, Morimoto T, Kawachi H, Ito M, Sato Y, Nagata K, Nakagawa A, Otsuka K, Uehara K, Imai Y, Ishida K, Fukuoka J, Tomii K.

J Thorac Oncol. 2017 Dec;12(12):1798-1805. doi: 10.1016/j.jtho.2017.08.022. Epub 2017 Sep 20.

PMID:
28939128
10.

Thin-section Computed Tomographic Findings of Multicentric Castleman Disease Changing Over 10 Years.

Tashiro H, Egashira R, Takahashi K, Fukui S, Nakazono T, Nojiri J, Fukuoka J, Irie H, Kimura S, Sueoka-Aragane N.

J Thorac Imaging. 2017 Nov;32(6):W81-W83. doi: 10.1097/RTI.0000000000000300. No abstract available.

PMID:
28914746
11.

Neoadjuvant hormonal therapy for low-risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis-related parameters.

Miyata Y, Nakamura Y, Yasuda T, Matsuo T, Ohba K, Furusato B, Fukuoka J, Sakai H.

Prostate. 2017 Oct;77(14):1408-1415. doi: 10.1002/pros.23402. Epub 2017 Aug 28.

12.

Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation.

Udo E, Furusato B, Sakai K, Prentice LM, Tanaka T, Kitamura Y, Tsuchiya T, Yamasaki N, Nagayasu T, Nishio K, Fukuoka J.

Diagn Pathol. 2017 Aug 22;12(1):62. doi: 10.1186/s13000-017-0651-2.

13.

Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.

Fujimoto J, Nunomura-Nakamura S, Liu Y, Lang W, McDowell T, Jakubek Y, Ezzeddine D, Kapere Ochieng J, Petersen J, Davies G, Fukuoka J, Wistuba II, Ehli E, Fowler J, Scheet P, Kadara H.

Int J Cancer. 2017 Oct 15;141(8):1589-1599. doi: 10.1002/ijc.30851. Epub 2017 Jul 17.

PMID:
28653505
14.

Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.

Kitano H, Chung JY, Noh KH, Lee YH, Kim TW, Lee SH, Eo SH, Cho HJ, Choi CH, Inoue S, Hanaoka J, Fukuoka J, Hewitt SM.

J Transl Med. 2017 Jun 17;15(1):138. doi: 10.1186/s12967-017-1241-5.

15.

Severe neutrophilic leukocytosis as a progression marker in granulocyte colony-stimulating factor-producing squamous cell carcinoma of the esophagus.

Yamaguchi S, Kanetaka K, Kobayashi S, Nagata Y, Kinosita N, Fukuoka J, Murakami S, Fujita F, Takatsuki M, Eguchi S.

Clin Case Rep. 2017 Mar 31;5(5):688-693. doi: 10.1002/ccr3.908. eCollection 2017 May.

16.

Expression of coproporphyrinogen oxidase is associated with detection of upper gastrointestinal carcinomas by 5-aminolevulinic acid-mediated photodynamic diagnosis.

Ogihara K, Isomoto H, Kurumi H, Kanda T, Hashisako M, Tabata K, Ishii H, Ohnita K, Yamaguchi N, Akazawa Y, Matsushima K, Takeshima F, Kunizaki M, Hidaka S, Nanashima A, Fukuoka J, Nagayasu T, Nakao K.

Photodiagnosis Photodyn Ther. 2017 Sep;19:15-21. doi: 10.1016/j.pdpdt.2017.04.003. Epub 2017 Apr 14.

PMID:
28416355
17.

Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy.

Ikutani M, Tsuneyama K, Kawaguchi M, Fukuoka J, Kudo F, Nakae S, Arita M, Nagai Y, Takaki S, Takatsu K.

JCI Insight. 2017 Apr 6;2(7):e90721. doi: 10.1172/jci.insight.90721.

18.

Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.

Fukihara J, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Furukawa T, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

BMC Pulm Med. 2017 Feb 6;17(1):30. doi: 10.1186/s12890-017-0376-8.

19.

Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer.

Matsuo T, Miyata Y, Asai A, Sagara Y, Furusato B, Fukuoka J, Sakai H.

PLoS One. 2017 Jan 31;12(1):e0171091. doi: 10.1371/journal.pone.0171091. eCollection 2017.

20.

The St. George's Respiratory Questionnaire as a prognostic factor in IPF.

Furukawa T, Taniguchi H, Ando M, Kondoh Y, Kataoka K, Nishiyama O, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

Respir Res. 2017 Jan 17;18(1):18. doi: 10.1186/s12931-017-0503-3.

21.

Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.

Ohue Y, Kurose K, Nozawa R, Isobe M, Nishio Y, Tanaka T, Doki Y, Hori T, Fukuoka J, Oka M, Nakayama E.

Cancer Immunol Res. 2016 Dec;4(12):1049-1060. Epub 2016 Oct 31.

22.

Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF.

Han SY, Ko A, Kitano H, Choi CH, Lee MS, Seo J, Fukuoka J, Kim SY, Hewitt SM, Chung JY, Song J.

Cancer Res. 2017 Jan 15;77(2):343-354. doi: 10.1158/0008-5472.CAN-16-0613. Epub 2016 Oct 28.

23.

Breakdown of lung framework and an increase in pores of Kohn as initial events of emphysema and a cause of reduction in diffusing capacity.

Yoshikawa A, Sato S, Tanaka T, Hashisako M, Kashima Y, Tsuchiya T, Yamasaki N, Nagayasu T, Yamamoto H, Fukuoka J.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 16;11:2287-2294. eCollection 2016.

24.

Interobserver Agreement of Usual Interstitial Pneumonia Diagnosis Correlated With Patient Outcome.

Hashisako M, Tanaka T, Terasaki Y, Uekusa T, Achcar RD, Aswad BI, Bamefleh HS, Capelozzi VL, English JC, Fabro AT, Kataoka K, Hayashi T, Kondoh Y, Taniguchi H, Fukuoka J.

Arch Pathol Lab Med. 2016 Dec;140(12):1375-1382. Epub 2016 Sep 9.

PMID:
27610646
25.

Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB.

Takaki M, Tanaka T, Komohara Y, Tsuchihashi Y, Mori D, Hayashi K, Fukuoka J, Yamasaki N, Nagayasu T, Ariyoshi K, Morimoto K, Nakata K.

Respir Med Case Rep. 2016 Aug 13;19:89-93. doi: 10.1016/j.rmcr.2016.06.011. eCollection 2016.

26.

A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).

Iwata T, Yoshino I, Yoshida S, Ikeda N, Tsuboi M, Asato Y, Katakami N, Sakamoto K, Yamashita Y, Okami J, Mitsudomi T, Yamashita M, Yokouchi H, Okubo K, Okada M, Takenoyama M, Chida M, Tomii K, Matsuura M, Azuma A, Iwasawa T, Kuwano K, Sakai S, Hiroshima K, Fukuoka J, Yoshimura K, Tada H, Nakagawa K, Nakanishi Y; West Japan Oncology Group.

Respir Res. 2016 Jul 22;17(1):90. doi: 10.1186/s12931-016-0398-4.

27.

Smoking-related interstitial fibrosis combined with pulmonary emphysema: computed tomography-pathologic correlative study using lobectomy specimens.

Otani H, Tanaka T, Murata K, Fukuoka J, Nitta N, Nagatani Y, Sonoda A, Takahashi M.

Int J Chron Obstruct Pulmon Dis. 2016 Jul 4;11:1521-32. doi: 10.2147/COPD.S107938. eCollection 2016.

28.

Pulmonary alveolar proteinosis-like change: A fairly common reaction associated with the severity of idiopathic pulmonary fibrosis.

Nunomura S, Tanaka T, Nakayama T, Otani K, Ishii H, Tabata K, Kondoh Y, Kataoka K, Johkoh T, Taniguchi H, Fukuoka J.

Respir Investig. 2016 Jul;54(4):272-9. doi: 10.1016/j.resinv.2016.02.004. Epub 2016 Mar 30.

PMID:
27424827
29.

Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.

Suzuki A, Kondoh Y, Taniguchi H, Tabata K, Kimura T, Kataoka K, Ono K, Hashisako M, Fukuoka J.

Respir Med Case Rep. 2016 May 28;19:5-8. doi: 10.1016/j.rmcr.2016.05.008. eCollection 2016.

30.

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kolb M, Lynch DA, Myers JL, Raghu G, Richeldi L, Taniguchi H, Martinez FJ.

Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75. doi: 10.1164/rccm.201604-0801CI. Review.

PMID:
27299520
31.

Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.

Walsh SL, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, Nunes H, Valeyre D, Brillet PY, Kambouchner M, Morais A, Pereira JM, Moura CS, Grutters JC, van den Heuvel DA, van Es HW, van Oosterhout MF, Seldenrijk CA, Bendstrup E, Rasmussen F, Madsen LB, Gooptu B, Pomplun S, Taniguchi H, Fukuoka J, Johkoh T, Nicholson AG, Sayer C, Edmunds L, Jacob J, Kokosi MA, Myers JL, Flaherty KR, Hansell DM.

Lancet Respir Med. 2016 Jul;4(7):557-65. doi: 10.1016/S2213-2600(16)30033-9. Epub 2016 May 11.

PMID:
27180021
32.

[The Safety and efficacy of airway-hyperresponsiveness test for asthma using by SK-1211 (Methacholine Chloride)].

Sagara H, Tanaka A, Ohta S, Jinno E, Uchida N, Sambe T, Hida N, Suehiro Y, Doi S, Kameda M, Yoshida Y, Fukuoka J, Kinoshita Y.

Arerugi. 2016 Feb;65(1):32-40. doi: 10.15036/arerugi.65.32. Japanese.

PMID:
26923652
33.

Thoracic Myoepithelial Tumors: A Pathologic and Molecular Study of 8 Cases With Review of the Literature.

Leduc C, Zhang L, Öz B, Luo J, Fukuoka J, Antonescu CR, Travis WD.

Am J Surg Pathol. 2016 Feb;40(2):212-23. doi: 10.1097/PAS.0000000000000560.

34.

Pheochromocytoma multisystem crisis treated with emergency surgery: a case report and literature review.

Kakoki K, Miyata Y, Shida Y, Hakariya T, Takehara K, Izumida S, Sekino M, Kinoshita N, Igawa T, Fukuoka J, Sakai H.

BMC Res Notes. 2015 Dec 9;8:758. doi: 10.1186/s13104-015-1738-z. Review.

35.

Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.

Nakamura H, Shimizu T, Takagi Y, Takahashi Y, Horai Y, Nakashima Y, Sato S, Shiraishi H, Nakamura T, Fukuoka J, Nakamura T, Kawakami A.

BMC Musculoskelet Disord. 2015 Nov 4;16:335. doi: 10.1186/s12891-015-0773-1.

36.

A case of spontaneous regression of pulmonary mucosa-associated lymphoid tissue (MALT) type lymphoma with Sjögren's syndrome treated with methotrexate for rheumatoid arthritis.

Yasui H, Nakamura Y, Hasegawa H, Fujisawa T, Enomoto N, Inui N, Fukuoka J, Suda T.

Respir Med Case Rep. 2015 Mar 3;15:4-6. doi: 10.1016/j.rmcr.2015.02.008. eCollection 2015.

37.

Pathological and radiological correlation in an autopsy case of combined pulmonary fibrosis and emphysema.

Karata H, Tanaka T, Egashira R, Tabata K, Otani K, Hayashi R, Hori T, Fukuoka J.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 8;10:1299-303. doi: 10.2147/COPD.S83521. eCollection 2015.

38.

Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.

Zhou Y, Yamada N, Tanaka T, Hori T, Yokoyama S, Hayakawa Y, Yano S, Fukuoka J, Koizumi K, Saiki I, Sakurai H.

Nat Commun. 2015 Jul 9;6:7679. doi: 10.1038/ncomms8679.

39.

Expression Analysis of p16, c-Myc, and mSin3A in Non-small Cell Lung Cancer by Computer Aided Scoring and Analysis (CASA).

Salmaninejad A, Estiar MA, Gill RK, Shih JH, Hewitt S, Jeon HS, Fukuoka J, Shilo K, Shakoori A, Jen J.

Clin Lab. 2015;61(5-6):549-59.

PMID:
26118188
40.

Lung-Dominant Connective Tissue Disease: Clinical, Radiologic, and Histologic Features.

Omote N, Taniguchi H, Kondoh Y, Watanabe N, Sakamoto K, Kimura T, Kataoka K, Johkoh T, Fujimoto K, Fukuoka J, Otani K, Nishiyama O, Hasegawa Y.

Chest. 2015 Dec;148(6):1438-1446. doi: 10.1378/chest.14-3174.

PMID:
25950648
41.

In vivo fluorescence navigation of gastric and upper gastrointestinal tumors by 5-aminolevulinic acid mediated photodynamic diagnosis with a laser-equipped video image endoscope.

Isomoto H, Nanashima A, Senoo T, Ogiwara K, Hashisako M, Ohnita K, Yamaguchi N, Kunizaki M, Hidaka S, Fukuda H, Ishii H, Matsushima K, Minami H, Akazawa Y, Takeshima F, Fukuoka J, Nagayasu T, Nakao K.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):201-8. doi: 10.1016/j.pdpdt.2015.03.006. Epub 2015 Mar 31.

PMID:
25840141
42.

Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias.

Kondoh Y, Johkoh T, Fukuoka J, Arakawa H, Tanaka T, Watanabe N, Sakamoto K, Kataoka K, Kimura T, Taniguchi H.

Respir Med. 2015 Mar;109(3):389-96. doi: 10.1016/j.rmed.2015.01.009. Epub 2015 Jan 31.

43.

Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease.

Fukihara J, Kondoh Y, Taniguchi H, Kimura T, Kataoka K, Matsuda T, Yokoyama T, Ono K, Kashima Y, Fukuoka J.

Eur Respir J. 2015 Mar;45(3):842-5. doi: 10.1183/09031936.00130314. Epub 2015 Feb 5. No abstract available.

44.

Rare idiopathic intestinal pneumonias (IIPs) and histologic patterns in new ATS/ERS multidisciplinary classification of the IIPs.

Johkoh T, Fukuoka J, Tanaka T.

Eur J Radiol. 2015 Mar;84(3):542-546. doi: 10.1016/j.ejrad.2014.11.032. Epub 2014 Dec 22.

PMID:
25591580
45.

Pathology of Idiopathic Interstitial Pneumonias.

Hashisako M, Fukuoka J.

Clin Med Insights Circ Respir Pulm Med. 2016 Feb 29;9(Suppl 1):123-33. doi: 10.4137/CCRPM.S23320. eCollection 2015. Review.

46.

A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L.

Hirai F, Yamanaka T, Taguchi K, Daga H, Ono A, Tanaka K, Kogure Y, Shimizu J, Kimura T, Fukuoka J, Iwamoto Y, Sasaki H, Takeda K, Seto T, Ichinose Y, Nakagawa K, Nakanishi Y; West Japan Oncology Group.

Ann Oncol. 2015 Feb;26(2):363-8. doi: 10.1093/annonc/mdu541. Epub 2014 Nov 17.

PMID:
25403584
47.

Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered.

Tabata K, Tanaka T, Hayashi T, Hori T, Nunomura S, Yonezawa S, Fukuoka J.

BMC Clin Pathol. 2014 May 13;14:23. doi: 10.1186/1472-6890-14-23. eCollection 2014.

48.

Anti-glycyl tRNA synthetase antibody associated interstitial lung disease without symptoms of polymyositis/dermatomyositis.

Hara Y, Tanaka T, Tabata K, Shiraki A, Hayashi K, Kashima Y, Hayashi T, Fukuoka J.

Pathol Int. 2014 Mar;64(3):148-50. doi: 10.1111/pin.12140. No abstract available.

PMID:
24698425
49.

Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.

Kume H, Muraoka S, Kuga T, Adachi J, Narumi R, Watanabe S, Kuwano M, Kodera Y, Matsushita K, Fukuoka J, Masuda T, Ishihama Y, Matsubara H, Nomura F, Tomonaga T.

Mol Cell Proteomics. 2014 Jun;13(6):1471-84. doi: 10.1074/mcp.M113.037093. Epub 2014 Mar 31.

50.

Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern.

Sumikawa H, Johkoh T, Fujimoto K, Arakawa H, Colby TV, Fukuoka J, Taniguchi H, Kondoh Y, Kataoka K, Ogura T, Baba T, Ichikado K, Gyobu T, Yanagawa M, Honda O, Tomiyama N.

Radiology. 2014 Aug;272(2):549-56. doi: 10.1148/radiol.14130853. Epub 2014 Mar 22.

PMID:
24661246

Supplemental Content

Loading ...
Support Center